Biocon's Bengaluru Facility Gets Four Observations from US FDA; No Business Impact Expected
Sept. 28, 2024, 3:23 p.m.
The US Food and Drug Administration (US FDA) conducted a surveillance inspection of Biocon's API facility in Bengaluru from 23rd to 27th September 2024.
Four observations were cited d…
Unlock the Full Filing And Lot More
Access premium insights and stay ahead of the market with Dzambhala Pro.